Arthrex® AR-501-TTLDRecalls & reported problems
Arthrex, Inc. · IBAL UKA TIB TRAY SZ 4,LFT-MEDIAL/RL · Class 2 · Implant
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00888867034150), received between Oct 20, 2023 and Oct 20, 2023 — classified as 1 injury.
The most frequently reported specific device problem is “Loosening of Implant Not Related to Bone-Ingrowth” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Reports received per month
Most reported problems
Device problems
- Loosening of Implant Not Related to Bone-Ingrowth1
Patient problems
- Unspecified Infection1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
InjuryOct 20, 2023Loosening of Implant Not Related to Bone-Ingrowth; Loosening of Implant Not Related to Bone-Ingrowth
ON (B)(6) 2022, IT WAS REPORTED BY THROUGH A PATIENT'S LEGAL FILING THAT ON (B)(6) 2017 THE PATIENT UNDERWENT A LEFT KNEE UNI-COMPARTMENTAL KNEE ARTHROPLASTY. DURING THE PROCEDURE THE SURGEON IMPLANTED AN ARTHREX IBALANCE UNI-COMPARTMENTAL KNEE SYSTEM WITH A SIZE 3 FEMORAL COMPONENT, SIZE 4 TIBIAL TRAY, AND AN 8 MM TIBIAL BEARING INSERT INTO THE LEFT KNEE MEDIAL PARAPATELLAR FACETECTOMY. THEREAFTER THE PATIENT WAS HAVING PAIN IN THE LEFT KNEE AND ON (B)(6) 2019 AN MRI OF THE KNEE WAS TAKEN WHICH REVEALED ¿METALLIC ARTIFACT IS PRESENT INVOLVING THE MEDIAL COMPARTMENT OBSCURING AND DISTORTING THE UNDERLYING AND ADJACENT STRUCTURES.¿ ON (B)(6) 2019 THE PATIENT REPORTED A CRUNCHING SENSATION ON THE MEDIAL ASPECT OF THE KNEE. ON (B)(6) 2019 AND AGAIN ON (B)(6) 2020 THE PATIENT COMPLAINED OF ACHES, PAINS AND WEAKNESS IN THE KNEE. ON (B)(6) 2020 THE PATIENT PRESENTED TO ANOTHER SURGEON AND A BONE SCAN WAS ORDERED WHICH REVEALED A LOOSE IMPLANT. THE PATIENT WAS REFERRED TO ANOTHER SURGEON TO DISCUSS REVISION OPTIONS DUE TO LOOSENING OF THE IMPLANT AND ON (B)(6), 2020 THAT SURGEON PERFORMED AN EXPLANTATION AND ANTIBIOTIC SPACER PLACEMENT, LEFT TOTAL KNEE ARTHROPLASTY AND SAUCERIZATION OF FE
Patient problems: Unspecified Infection
MAUDE report 17980950 ↗
Other PROSTHESIS, KNEE, FEMOROTIBIAL, NON-CONSTRAINED, CEMENTED, METAL/POLYMER devices
- LinkSymphoKnee 880-307/21WALDEMAR LINK GmbH & Co. KG · PROSTHESIS, KNEE, FEMOROTIBIAL, NON-CONSTRAINED, CEMENTED, METAL/POLYMER2 recalls2 reports
- Scorpio 73-3710Howmedica Osteonics Corp. · PROSTHESIS, KNEE, FEMOROTIBIAL, NON-CONSTRAINED, CEMENTED, METAL/POLYMER2 recalls1 report
- Scorpio 73-3110Howmedica Osteonics Corp. · PROSTHESIS, KNEE, FEMOROTIBIAL, NON-CONSTRAINED, CEMENTED, METAL/POLYMER2 recalls0 reports
- Arthrex® AR-503-TTTEArthrex, Inc. · PROSTHESIS, KNEE, FEMOROTIBIAL, NON-CONSTRAINED, CEMENTED, METAL/POLYMER1 recall14 reports
- Arthrex® AR-503-TTTJArthrex, Inc. · PROSTHESIS, KNEE, FEMOROTIBIAL, NON-CONSTRAINED, CEMENTED, METAL/POLYMER1 recall9 reports
- Arthrex® AR-503-TTTGArthrex, Inc. · PROSTHESIS, KNEE, FEMOROTIBIAL, NON-CONSTRAINED, CEMENTED, METAL/POLYMER1 recall7 reports
- ENGAGE 1-10011-300Smith & Nephew, Inc. · PROSTHESIS, KNEE, FEMOROTIBIAL, NON-CONSTRAINED, CEMENTED, METAL/POLYMER1 recall7 reports
- ENGAGE 1-10003-400Smith & Nephew, Inc. · PROSTHESIS, KNEE, FEMOROTIBIAL, NON-CONSTRAINED, CEMENTED, METAL/POLYMER1 recall6 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page